Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
0.919
+0.047 (5.39%)
At close: Feb 21, 2025, 4:00 PM
0.880
-0.039 (-4.23%)
After-hours: Feb 21, 2025, 7:59 PM EST
Imunon Market Cap
Imunon has a market cap or net worth of $13.33 million as of February 21, 2025. Its market cap has increased by 146.78% in one year.
Market Cap
13.33M
Enterprise Value
4.28M
1-Year Change
146.78%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since March 1, 1999, Imunon's market cap has decreased from $37.80M to $13.33M, a decrease of -64.75%. That is a compound annual growth rate of -3.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 13.30M | -3.62% |
| Dec 31, 2024 | 13.80M | 115.63% |
| Dec 29, 2023 | 6.40M | -36.00% |
| Dec 30, 2022 | 10.00M | -78.59% |
| Dec 31, 2021 | 46.70M | 75.56% |
| Dec 31, 2020 | 26.60M | -31.62% |
| Dec 31, 2019 | 38.90M | 47.35% |
| Dec 31, 2018 | 26.40M | -38.60% |
| Dec 29, 2017 | 43.00M | 444.30% |
| Dec 30, 2016 | 7.90M | -82.29% |
| Dec 31, 2015 | 44.60M | -4.09% |
| Dec 31, 2014 | 46.50M | -12.10% |
| Dec 31, 2013 | 52.90M | -81.56% |
| Dec 31, 2012 | 286.80M | 531.72% |
| Dec 30, 2011 | 45.40M | 73.95% |
| Dec 31, 2010 | 26.10M | -34.09% |
| Dec 31, 2009 | 39.60M | 77.58% |
| Dec 31, 2008 | 22.30M | -30.75% |
| Dec 31, 2007 | 32.20M | 57.07% |
| Dec 29, 2006 | 20.50M | -52.76% |
| Dec 30, 2005 | 43.40M | -52.62% |
| Dec 31, 2004 | 91.60M | -52.73% |
| Dec 31, 2003 | 193.80M | 366.99% |
| Dec 31, 2002 | 41.50M | -26.29% |
| Dec 31, 2001 | 56.30M | -12.71% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |